Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia-Reference-Cited by-同舟云学术

Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia

Published:2022-01-01 Issue:1 Volume:8 Page:79
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kutny Matthew A.¹,Alonzo Todd A.²,Abla Oussama³,Rajpurkar Madhvi⁴,Gerbing Robert B.⁵,Wang Yi-Cheng⁵,Hirsch Betsy A.⁶,Raimondi Susana⁷,Kahwash Samir⁸,Hardy Kristina K.⁹,Hardy Steven⁹,Meshinchi Soheil¹⁰,Gamis Alan S.¹¹,Kolb Edward A.¹²,Feusner James H.¹³,Gregory John¹⁴

Affiliation:

1. Division of Hematology/Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham

2. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles

3. Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada

4. Pediatric Hematology/Oncology, Wayne State University, Detroit, Michigan

5. Children’s Oncology Group, Monrovia, California

6. Division of Laboratory Medicine, University of Minnesota Medical Center–Fairview, Minneapolis

7. Department of Pathology, St Jude Children’s Research Hospital, Memphis, Tennessee

8. Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, Columbus, Ohio

9. Division of Behavioral Medicine/Neuropsychology, Children’s National Medical Center, Washington, District of Columbia

10. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

11. Division of Hematology/Oncology, Children’s Mercy Hospital and Clinics, Kansas City, Missouri

12. Division of Pediatric Hematology/Oncology, Nemours/Alfred I. DuPont Hospital for Children, Wilmington, Delaware

13. Division of Hematology/Oncology, Benioff Children’s Hospital Oakland, Oakland, California

14. Division of Pediatric Hematology/Oncology, Atlantic Health System, Goryeb Children’s Hospital, Morristown, New Jersey

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2786069/jamaoncology_kutny_2021_oi_210076_1642642460.49059.pdf

Reference31 articles.

1. Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.;Gregory;Pediatr Blood Cancer,2009

2. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.;Testi;Blood,2005

3. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.;Thomas;Ann Hematol,2002

4. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children’s Oncology Group.;Shankar;Pediatrics,2008

5. Arsenic trioxide consolidation allows anthracycline dose reduction for pediatric patients with acute promyelocytic leukemia: report from the Children’s Oncology Group phase III historically controlled trial AAML0631.;Kutny;J Clin Oncol,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects;Cancers;2024-01-26

2. Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date;Archives of Pharmacal Research;2023-12-26

3. Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group;Blood Cancer Journal;2023-12-05

4. Tumor microenvironment-responsive arsenic-loaded layered double hydroxides film with synergistic anticancer and bactericidal activity;Rare Metals;2023-12-02

5. Recent advances in the treatment of childhood cancers;Current Opinion in Pediatrics;2023-11-14